Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Valuation
P/E Ratio
31.35x
Forward P/E
22.18x
EPS
8.71
PEG Ratio
4.73x
P/B Ratio
7.74x
Beta
0.23
Profitability
Revenue Growth
6.60%
Earnings Growth
-0.90%
Gross Margin
68.14%
Operating Margin
29.19%
Net Margin
21.48%
Return on Equity
25.74%
Return on Assets
8.60%
Financial Health
Debt / Equity
0.58x
Current Ratio
1.09x
Quick Ratio
0.72x
Free Cash Flow
16.9B
Dividends
Dividend Yield
1.98%
Payout Ratio
60.79%
Ex-Dividend Date
2026-08-25
Source: Yahoo Finance
Price Target
Low
$190.00
Average
$272.50
High
$305.00
Source: Yahoo Finance